Hinds J A, Pincombe C F, Smith S, Duffy P
Clin Chim Acta. 1985 Jul 15;149(2-3):105-15. doi: 10.1016/0009-8981(85)90324-9.
We describe a clinically useful ligand displacement immunoassay for the measurement of serum or plasma phenobarbital and phenytoin. A conjugate of drug-specific antiserum covalently bound to micro-crystalline cellulose and a beta-galactosidase-labelled drug derivative is prepared as a lyophilized reagent. Sample is added to the conjugate and, after 5-min incubation at room temperature, the bound and displaced enzyme-ligand are separated by brief centrifugation. The enzyme activity of the displaced enzyme-ligand is measured on a spectrophotometer or centrifugal analyser. Linear calibration curves are obtained with appropriate sample dilution, allowing generation of the standard curve with a saline zero reference and a single calibrator. The performance of the assay compared favourably with other immunoassays; comparison studies with clinical specimens gave a correlation with EMIT of 0.96 (n = 122) for phenobarbital and 0.95 (n = 96) for phenytoin.
我们描述了一种用于测量血清或血浆中苯巴比妥和苯妥英的临床实用配体置换免疫测定法。将与微晶纤维素共价结合的药物特异性抗血清与β-半乳糖苷酶标记的药物衍生物的结合物制备成冻干试剂。将样品加入结合物中,在室温下孵育5分钟后,通过短暂离心分离结合的和置换的酶-配体。用分光光度计或离心分析仪测量置换的酶-配体的酶活性。通过适当的样品稀释可获得线性校准曲线,从而可以用生理盐水零对照和单一校准物生成标准曲线。该测定法的性能优于其他免疫测定法;与临床标本的比较研究表明,苯巴比妥与EMIT的相关性为0.96(n = 122),苯妥英与EMIT的相关性为0.95(n = 96)。